Polymerase chain reaction test kits for detecting markers of bladder cancer
US9982305B2 · kind B2 · utility
0Cited by
4References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 11, 2011 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | Aug 28, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7155
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
This invention relates to the use of human neutrophil marker interleukin 8 receptor B (IL8Rb) for detection of bladder cancer, and more particularly to the use of EL8Rb for discriminating between transitional cell carcinoma of the bladder (TCC) and inflammatory conditions of the bladder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.